Skip to main contentAI and Advanced
/
GLPL · BSEMarket ticker unavailable · configure an authorised index feed
GL
BSE · Equity shares · Not available-0.25 · -0.68%
GOLDLINE PHARMACEUTICAL LIMITE GLPL
NSE:Not available
BSE:INR 36.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsData unavailable
Research sections2 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
This listed security has price history but no canonical company-fundamentals document. Financials, valuation, ownership and company-profile gaps are source coverage gaps, not zero values.
AI analysis and Advanced tools for GLPL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 36.75
Day rangeINR 36 — INR 36.5
52-week rangeINR 33 — INR 60
Volume15,000
Market capNot available
P/ENot available
Research path: Interpret GOLDLINE PHARMACEUTICAL LIMITE's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
GLPLGOLDLINE PHARMACEUTICAL LIMITE1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
Financial statement rows are unavailable.
Fundamentals
Valuation and ratios
Valuation data unavailable.
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
Ownership data is not present in the normalized source.
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Relevant company news is unavailable.
Corporate actions
Events
Corporate event data unavailable.
Rusaka Markets Community
Discussion and sentiment for GOLDLINE PHARMACEUTICAL LIMITE
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- NSE Code
- GLPL
Questions
Stock FAQ
What is the symbol and ISIN of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has the symbol GLPL and ISIN - INE1CLW01015.
What is the current price of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE is currently trading at INR 36.50.
What are the year high and year low of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a year high of INR 60.00 and a year low of INR 33.00.
What is the market capitalization of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a market capitalization of NA.
What is the P/E ratio of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a P/E ratio of NA.
What is the dividend yield of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a dividend yield of NA.
How is the financial performance of GOLDLINE PHARMACEUTICAL LIMITE based on revenue, net income, and EPS?
GOLDLINE PHARMACEUTICAL LIMITE has revenue of NA, net income of NA, and EPS of NA.
What is the book value of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a book value of NA.
What is the debt-to-equity ratio of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of GOLDLINE PHARMACEUTICAL LIMITE?
GOLDLINE PHARMACEUTICAL LIMITE has a price-to-book ratio of NA and a price-to-sales ratio of NA.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.